✦ LIBER ✦

Opioid responsiveness in patients with advanced head and neck cancer

✍ Scribed by Sebastiano Mercadante

Publisher: Springer-Verlag
Year: 1998
Tongue: English
Weight: 57 KB
Volume: 6
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s005200050199

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Planned postradiotherapy neck dissection

Planned postradiotherapy neck dissection in patients with advanced head and neck cancer

✍ Timothy S. Boyd; Paul M. Harari; Scott P. Tannehill; Marta C. Voytovich; Gregory 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Background: Metastatic neck nodes in patients with squamous cell carcinoma of the head and neck are most commonly managed by surgery, radiotherapy, or combined-modality therapy. for combined-modality cases, the sequencing of surgery and radiotherapy is generally guided by which modality is consi

Factors that affect response to chemothe

Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer

✍ Magid H. Amer; Muhyi Al-Sarraf; Vainutis K. Vaitkevicius 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

A review of 164 patients with far advanced head and neck cancer, treated by a cytotoxic chemotherapy over a ten year period, at WAyne State University, Detroit, Michigan, was done in an attempt to determine factors that may influence the response to chemotherapy and subsequent survival. Response rat

Neck dissection in the combined-modality

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer

✍ Athanassios Argiris; Kerstin M. Stenson; Bruce E. Brockstein; Bharat B. Mittal; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

## Abstract ## Purpose. The purpose of this study was to evaluate the role of neck lymph node (ND) in the combined dissection modality therapy for locoregionally advanced head and neck. ## Methods. We identified patients with N2–N3 head and neck cancers who were enrolled in three consecutive mul

Cell-mediated immune response in head an

Cell-mediated immune response in head and neck cancer patients

✍ Dr. A. Olivari; R. Pradier; J. Feierstein; A. Guardo; H. Glait; A. Rojas 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

## Abstract The immune reactivity of 100 head and neck cancer patients was studied by means of DNCB, candidine, blastic transformation with PHA, and lymphocyte counts. DNCB reactivity was strong in only 21% of the population and was found impaired in patients with advanced primitive tumors, with m

Circulating immune complexes and chemoth

Circulating immune complexes and chemotherapy response in patients with head and neck cancer

✍ Beverly A. Blazar; Dr. Marvin P. Fried; Marshall Strome; John R. Clark; Patricia 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

An assay which could prospectively predict a response to chemotherapy prior to instituting therapy would be beneficial, especially for nonresponders. We evaluated at random a total of 50 patients with previously untreated stage 111 and IV head and neck squamous cell carcinoma for T-cell subsets and

Photo-chemotherapy in advanced head and

Photo-chemotherapy in advanced head and neck cancer

✍ Jacobs, John R. ;Weaver, Arthur ;Ahmed, Khurshid ;Crissman, John ;Ensley, John F 📂 Article 📅 1987 🏛 Wiley (John Wiley & Sons) ⚖ 526 KB

Induction (proto) chemotherapy consisting of 3 courses of cisplatin and 120-hour 5-fluorouracil infusion was administered to 88 patients who had locally advanced, previously untreated head and neck cancer. The majority (81%) of these patients were classified as stage IV, and 17% had second primary c